Trial Profile
Study of Tolvaptan in Patients with Liver Cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2018
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2018 New trial record
- 13 Nov 2018 Results presented at The Liver Meeting 2018: 69th Annual Meeting of the American Association for the Study of Liver Diseases